Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,305-2,316 of 4,306
Drug study icon
CompletedNCT01488929

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

This study is completed in the United States, in Hungary, in Romania, .... It focuses on schizophrenia.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Hungary, Romania, ...
Sponsor
Targacept Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00042224

Electroconvulsive Therapy in Clozapine Refractory Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Glen Oaks
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
Other study type icon
CompletedNCT00001921

Electrophysiology and Blood Flow in people with Schizophrenia and Their Siblings

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 55 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
Behavioral study icon
TerminatedNCT01817387

Enhancing Motivation in Recent Onset Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 14 Years to 30 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01776112

Enhancing Synaptic Plasticity and Cognition in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Göttingen
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
Germany
Sponsor
University Medical Center Goettingen
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00069433

Enhancing the Outcome of Skills Training for People With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bridgeport
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
CompletedNCT00192855

Entacapone Augmentation for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Haifa
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 75 Years
Countries
Israel
Sponsor
Rambam Health Care Campus
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.